记忆门诊无痴呆患者中的空间导航及其与生物标志物和未来痴呆的关联
该研究纳入BioFINDER纵向队列中无痴呆的记忆门诊患者,包括156例主观认知下降(SCD)和176例轻度认知障碍(MCI)患者,采用地板迷宫测试(FMT)评估基线空间导航。结果显示FMT总时间与2年和4年随访时进展为全因痴呆相关(模型2中OR均为1.10,95%CI 1.04-1.16,即FMT每增加10秒痴呆 odds 增加10%),且与P-tau、NfL及海马体积、海马旁回和下顶叶皮层厚度相关。
要点
- FMT总时间与2年和4年随访时进展为全因痴呆相关,模型2中OR均为1.10(95%CI 1.04-1.16)。
- 调整分析中,P-tau和NfL与FMT总时间相关,海马体积、海马旁回和下顶叶皮层厚度也与FMT总时间相关。
- 淀粉样蛋白-β 42/40比值与FMT总时间无关联。
核心结论
- 在SCD和MCI患者中,空间导航受损与2年和4年内进展为痴呆相关,并与AD和神经变性的关键脑脊液和MRI生物标志物相关。
- 作者认为这支持将空间导航用于早期认知评估,但预测准确性应在其他队列中验证。
研究设计与样本
- 本研究为纵向BioFINDER队列中的前瞻性队列研究(证据分类为Class I),纳入无痴呆的记忆门诊患者。
- 共纳入156例SCD患者和176例MCI患者,基线采用地板迷宫测试(FMT)评估空间导航,并在2年和4年随访时评估痴呆转化。
- 基线时分析脑脊液淀粉样蛋白-β 42/40比值、磷酸化tau(P-tau)和神经丝轻链(NfL),并通过MRI量化导航相关区域皮层厚度和体积以及白质病变体积。
主要发现
- FMT总时间与进展为全因痴呆在模型2中2年随访时相关(OR 1.10,95%CI 1.04-1.16),4年随访时也相关(OR 1.10,95%CI 1.04-1.16),即FMT每增加10秒痴呆 odds 增加10%。
- 调整分析中,P-tau和NfL与FMT总时间相关,海马体积、海马旁回和下顶叶皮层厚度也与FMT总时间相关。
- 淀粉样蛋白-β 42/40比值与FMT总时间无关联。
局限性
- 作者指出预测准确性应在其他队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Impaired spatial navigation is considered an early sign in many neurodegenerative diseases. We aimed to determine whether spatial navigation was associated with future dementia in patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) and to explore associations between spatial navigation and biomarkers of Alzheimer disease (AD) and neurodegeneration. METHODS: This study included memory clinic patients without dementia in the longitudinal BioFINDER cohort. The Floor Maze Test (FMT) was used to assess spatial navigation at baseline. Conversion to dementia was evaluated at 2-year and 4-year follow-ups. At baseline, amyloid-β 42/40 ratio, phosphorylated-tau (P-tau), and neurofilament light (NfL) were analyzed in CSF. Cortical thickness and volume of regions relevant for navigation and white matter lesion volume were quantified from MRI. The predictive role of the FMT for conversion to all-cause dementia was analyzed using logistic regression analyses in 2 models: (1) controlled for age, sex, and education and (2) adding baseline cognitive status and MMSE. Associations between FMT and biomarkers were adjusted for age, sex, and cognitive status (SCD or MCI). RESULTS: One hundred fifty-six patients with SCD and 176 patients with MCI were included. FMT total time was associated with progression to all-cause dementia in model 2 at 2-year (OR 1.10, 95% CI 1.04-1.16) and at 4-year follow-up (OR 1.10, 95% CI 1.04-1.16), i.e., a 10% increase in odds of developing dementia per every 10 seconds increase in FMT. In the adjusted analyses, P-tau and NfL were associated with FMT total time, as well as hippocampal volume, parahippocampal, and inferior parietal cortical thickness. Amyloid-β 42/40 ratio was not associated with FMT total time. DISCUSSION: Impaired spatial navigation was associated with conversion to dementia within 2 and 4 years and with key CSF and MRI biomarkers for AD and neurodegeneration in patients with SCD and MCI. This supports its use in early cognitive assessments, but the predictive accuracy should be validated in other cohorts. CLASSIFICATION OF EVIDENCE: This is a Class I prospective cohort study demonstrating association of baseline markers of spatial recognition with development of dementia in patients with SCD or MCI at baseline.
引用
- Tangen GG, Nilsson MH, Stomrud E, et al. Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia. Neurology. 2022. PMID: 36028328. doi:10.1212/WNL.0000000000201106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。